A kidney lesion is any abnormal area of tissue in or on the kidney, ranging from a harmless fluid-filled cyst to a cancerous tumor. The term itself is intentionally broad: doctors use “lesion” as a neutral label before they know what they’re dealing with. Most kidney lesions are discovered by accident during imaging done for an unrelated reason, and it’s estimated that over half of people older than 50 have at least one kidney mass show up on a scan.1PubMed Central. Management of incidental renal masses: Time to consider contrast-enhanced ultrasonography That statistic sounds alarming, but the vast majority turn out to be benign cysts that never need treatment.
Why So Many Kidney Lesions Are Found by Accident
The kidneys sit deep in the abdomen, well protected by other organs and by fat, so most lesions produce no symptoms until they’ve grown large or caused a complication like bleeding. The real reason kidney lesions are diagnosed more often now than a few decades ago has less to do with kidneys getting sicker and more to do with people getting scanned more. CT scans, MRIs, and ultrasounds done for back pain, abdominal complaints, or routine check-ups regularly pick up kidney findings the patient never suspected. This flood of incidental discoveries creates a practical problem: a radiologist sees something that looks like a spot on the kidney, and now someone has to figure out whether it matters. The answer depends entirely on what type of lesion it is.
Simple and Complex Cysts
The most common kidney lesion is a simple cyst, a round pocket of fluid with a thin, smooth wall and nothing solid inside it. Simple cysts are almost always harmless. They don’t become cancer, rarely cause pain unless they grow very large, and typically require no treatment at all. They become increasingly common with age, and many people have several without ever knowing.
Where things get more complicated is with complex cysts. A cyst earns the label “complex” when it has features that look unusual on imaging: thickened walls, internal divisions called septations, areas of calcification, or solid-looking components. Complex cysts exist on a spectrum. Some are only slightly more complicated than a simple cyst and carry a very low risk of being cancerous. Others have enough suspicious features that they may need to be surgically removed.
To sort out where a complex cyst falls on that spectrum, radiologists have used a grading system called the Bosniak classification for over three decades.2PubMed Central. Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment The system groups cystic lesions into categories based on how they appear on CT or MRI, and each category carries a different probability of malignancy. A large meta-analysis found that the pooled malignancy rate climbed from roughly 3% for the simplest category up to about 91% for the most suspicious-looking category, with the intermediate categories falling in between at around 6–7% and about 55%.3PubMed Central. Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography – a systematic review and meta-analysis The middle categories are the trickiest: a lesion graded as moderately complex (Bosniak III) has roughly a coin-flip chance of being malignant. One study found that about 60% of Bosniak III lesions turned out to be cancer, and somewhat counterintuitively, the smaller ones were more likely to be malignant than the larger ones.4PubMed Central. The true malignancy risk of Bosniak III cystic renal lesions: Active surveillance or surgical resection?
This grading system was updated in 2019 to better reflect modern imaging capabilities, but the core idea remains the same: the more complex a cyst looks, the more seriously it needs to be evaluated. Simple cysts can be left alone. Minimally complex cysts get periodic follow-up scans. Highly complex cysts often need surgery or biopsy.
Benign Solid Masses
Not every solid kidney mass is cancer. Two of the most common benign solid lesions are angiomyolipomas and oncocytomas, and distinguishing them from malignant tumors before surgery is one of the persistent challenges in kidney medicine.
An angiomyolipoma is a tumor made up of blood vessels, smooth muscle, and fat. Because fat has a distinctive appearance on CT scans, most angiomyolipomas are straightforward to identify on imaging. Small ones are usually left alone. Larger ones, or those with certain worrisome features, may need treatment because they can bleed. Traditionally, size alone was used to decide when to intervene, with 4 centimeters being a common threshold. But research has pointed out that other features also predict bleeding risk, including the presence of small aneurysms inside the lesion, how vascular the tumor is, and whether it has less fat than a typical angiomyolipoma.5Research and Reports in Urology. Is Size All That Matters? New Predictors of Complications and Bleeding in Renal Angiomyolipoma In other words, a smaller angiomyolipoma with unusual blood flow patterns could be riskier than a larger one with the classic fatty appearance.
Oncocytomas are another type of benign solid kidney tumor, and they present a different problem. They look similar to a specific type of kidney cancer called chromophobe renal cell carcinoma under the microscope, and telling them apart reliably is surprisingly difficult even for expert pathologists. Surveys of urologic pathologists have shown that there isn’t even full agreement on the exact criteria used to distinguish the two. Pathologists rely on a combination of staining techniques and chromosomal analysis, but there’s no single definitive test.6Elsevier / Human Pathology. Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists This diagnostic gray zone means some patients end up having surgery for what turns out to be a benign oncocytoma, because the risk of it being cancer can’t be ruled out beforehand.
Renal Cell Carcinoma and Other Malignant Tumors
When a kidney lesion does turn out to be cancer, the most common type by far is renal cell carcinoma. It’s not a single disease but a family of cancers with distinct subtypes that behave differently and respond to different treatments.
Clear cell renal cell carcinoma accounts for roughly 80% of all kidney cancers.7PubMed. Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective The name comes from the way the tumor cells look under a microscope: pale and “clear” because they’re packed with fat and glycogen that washes out during tissue preparation. Most clear cell tumors involve a defect in a gene called VHL. When this gene stops working properly, it triggers a cascade of events, including the overactivation of pathways that promote new blood vessel growth, which is why these tumors tend to be highly vascular. This biology also explains why clear cell kidney cancer is famously resistant to standard chemotherapy but responds to drugs that target blood vessel formation.8PubMed Central. Molecular genetics of clear-cell renal cell carcinoma
Papillary renal cell carcinoma is the second most common subtype. It comes in two forms with different genetic underpinnings and outcomes. Chromophobe renal cell carcinoma is rarer and tends to have a better prognosis than clear cell or papillary types, though treatment options for advanced cases remain limited.9PubMed Central. Chromophobe renal cell carcinoma – a rare kidney cancer with limited therapy options: a narrative review The classification of kidney cancers continues to evolve; the 2022 World Health Organization update revised how papillary and chromophobe subtypes are categorized and introduced several emerging tumor entities.10PubMed. WHO 2022 landscape of papillary and chromophobe renal cell carcinoma
Infectious and Inflammatory Lesions
Kidney lesions aren’t always about growths or tumors. Infections can produce masses in the kidney that look confusingly similar to cancer on a scan. Acute focal bacterial nephritis is a localized bacterial infection that creates an inflammatory mass in the kidney tissue.11Scientific Reports. Clinical features of acute focal bacterial nephritis in adults It can progress to a full-blown abscess if untreated, and on ultrasound or CT it may be hard to tell apart from a kidney tumor or abscess.12PubMed. Diagnosis and treatment of acute focal bacterial nephritis Clinical context matters enormously here: a patient with fever, flank pain, and an elevated white blood cell count who has an odd-looking kidney mass is much more likely dealing with an infection than a cancer.
Tuberculosis can also involve the kidneys and produce a variety of lesions, from subtle changes in the calyces (the internal drainage structures of the kidney) to lobar calcification, tissue destruction, and scarring. Kidney TB can be tricky to diagnose because cultures sometimes come back negative, and some of its complications, like a specific type of interstitial inflammation, can quietly damage kidney function without obvious signs.13PubMed Central. Tuberculosis of the genitourinary system-Urinary tract tuberculosis: Renal tuberculosis-Part I
Autoimmune and Drug-Induced Lesions
The immune system and certain medications can also generate kidney lesions that mimic tumors. IgG4-related disease is an autoimmune condition that can produce mass-like inflammatory deposits in multiple organs, including the kidneys. A case study documented a kidney mass that was initially suspected to be malignant; biopsy revealed dense infiltration of immune cells and fibrosis with no evidence of cancer, consistent with IgG4-related disease affecting multiple organs simultaneously.14Urology Case Reports. IgG4-related pseudo-tumor of the kidney and multiple organ involvement mimicked malignancy Recognizing this condition matters because it responds to immunosuppressive therapy rather than surgery.
On the medication side, long-term lithium use (commonly prescribed for bipolar disorder) can cause chronic damage to the kidney’s tubules and interstitial tissue, eventually leading to the formation of small cysts, known as microcysts, scattered throughout the kidney.15PubMed Central. Lithium-associated kidney microcysts This type of kidney injury is characterized by tubular atrophy and scarring interspersed with these tiny cysts. The good news is that this kind of toxicity is uncommon overall, and the biggest risk factors are high blood levels of lithium sustained over many years.16PubMed Central. What we need to know about the effect of lithium on the kidney Regular monitoring of kidney function and lithium levels helps catch problems early.
Vascular Lesions
A renal infarction occurs when blood supply to part of the kidney is suddenly cut off, killing a wedge-shaped area of tissue. On a CT scan, this dead zone shows up as a region that doesn’t take up contrast dye, and it can be mistaken for other types of lesions if the clinical picture isn’t clear. In a large study of over 400 cases, the most common cause was cardiogenic, meaning a blood clot originating from the heart (accounting for about 56% of cases). Injury to the renal artery itself and hypercoagulable conditions together made up another 14%, while about 30% of cases had no identifiable cause.17PubMed. Clinical Characteristics and Outcomes of Renal Infarction The typical symptom is sudden, severe flank pain, often with nausea, and it can easily be confused with a kidney stone.
Polycystic Kidney Disease
While most cysts are isolated and benign, some people develop hundreds or thousands of them due to an inherited condition called polycystic kidney disease (PKD). Most cases are caused by mutations in one of two genes, PKD1 or PKD2, which encode proteins that form a signaling complex on the cell surface.18PubMed Central. Mechanisms of Cyst Development in Polycystic Kidney Disease When this complex loses function below a certain threshold, cyst formation is triggered, and the cysts progressively enlarge over years or decades.
The underlying biology involves structures called primary cilia, tiny antenna-like projections on the surface of kidney cells that help regulate cell growth and maintain the proper diameter of the kidney’s tubules. When these cilia don’t function correctly, the signaling that normally keeps kidney tubes the right size goes haywire, and cells begin to proliferate and form fluid-filled sacs.19PubMed Central. Advances in the pathogenesis and treatment of polycystic kidney disease PKD kidneys can grow enormously large and eventually lose their ability to filter blood, leading to kidney failure. Unlike solitary simple cysts, which are generally an incidental finding with no consequences, a PKD diagnosis has major implications for long-term health and may affect family planning decisions since the condition is inherited.
Anatomic Mimics That Aren’t Lesions at All
Sometimes what looks like a kidney lesion on imaging isn’t a lesion at all. These so-called pseudotumors are normal anatomical variants or benign tissue changes that mimic the appearance of a mass.20PubMed. Renal pseudotumors One of the most common is a hypertrophied column of Bertin, which occurs when the normal cortical tissue of the kidney extends inward between the drainage structures more prominently than usual, creating a bulge that can look like a solid mass. This variant is particularly likely to cause confusion in children, where the anatomy is smaller and pseudotumors are relatively more prevalent.21PubMed Central. Hypertrophied Column of Bertin Mimicking a Renal Tumor in a Child: A Diagnostic Challenge
Other pseudotumors include prominent fetal lobulations (where the kidney retains an irregular surface contour from fetal development), dromedary humps (a focal bulge on the left kidney caused by the spleen pressing on it), and areas of scarring or compensatory growth after injury. Recognizing these as normal variants prevents unnecessary biopsies and surgeries. The key is that pseudotumors are made up of normal kidney tissue and enhance on contrast imaging exactly the same way the surrounding kidney does, whereas true tumors typically have a different enhancement pattern.
When Kidney Tumors Cause Symptoms Elsewhere
Renal cell carcinoma has a reputation as a “great mimic” in medicine because it can cause a wide array of symptoms that seem to have nothing to do with the kidneys. Close to one third of patients with renal cell carcinoma show signs of a paraneoplastic syndrome, meaning the tumor triggers effects in other parts of the body by releasing hormones, cytokines, or other substances into the bloodstream.22PubMed Central. Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma
These syndromes vary widely. In one study of patients with kidney cancer, the most common findings were anemia (about 60%), an elevated inflammatory marker called ESR (about 55%), and high blood pressure (about 16%). A condition called Stauffer’s syndrome, where the liver stops functioning properly even though the cancer hasn’t spread there, appeared in about 12% of cases. Elevated calcium levels in the blood occurred in about 7%.23Nigerian Journal of Clinical Practice. Paraneoplastic Syndromes and Oncological Outcomes in Renal Cancer In extreme cases, high calcium caused by kidney cancer can lead to confusion, lethargy, and even coma.24PubMed Central. Renal cell carcinoma presenting with paraneoplastic hypercalcemic coma: a case report and review of the literature The point for patients is that unexplained symptoms like persistent fatigue, unexplained fevers, weight loss, or abnormal blood work can sometimes be the first sign of a kidney tumor.
How Small Kidney Masses Are Managed
Finding a small suspicious mass on the kidney doesn’t automatically mean rushing to the operating room. Over the past two decades, the management of small renal masses (generally defined as 4 centimeters or less) has shifted considerably. Active surveillance, meaning regular imaging to track growth over time rather than immediate treatment, has emerged as a safe strategy for many patients, particularly older adults or those with serious health conditions that make surgery risky.25PubMed Central. Active Surveillance for Small Renal Masses Studies have consistently found that fewer than 2% of patients on active surveillance go on to develop metastatic disease.26PubMed Central. Active surveillance for small renal masses
The challenge is that no single test or biomarker can reliably tell a doctor before treatment whether a small kidney mass is benign or malignant. Biopsy of kidney masses remains somewhat controversial because of sampling error and the difficulty of distinguishing borderline tumors like oncocytomas from low-grade cancers.27PubMed Central. Current Management of Small Renal Masses, Including Patient Selection, Renal Tumor Biopsy, Active Surveillance, and Thermal Ablation When treatment is chosen, options range from partial removal of the kidney (partial nephrectomy) to thermal ablation, which uses extreme heat or cold to destroy the tumor without open surgery. The choice depends on the size and location of the mass, the patient’s overall health, and how likely the lesion is to be cancer based on its imaging characteristics.
Liquid Biopsies and Future Diagnostics
One of the frustrations with kidney masses is the gap between finding them on a scan and knowing what they are. Researchers are working on blood- and urine-based tests, known as liquid biopsies, that could fill this gap without requiring a needle to be inserted into the kidney. The most promising approaches involve detecting circulating tumor cells, tiny membrane-wrapped packages called extracellular vesicles, and fragments of tumor DNA floating freely in the bloodstream.28Nature Reviews Urology. Diagnostic liquid biopsy biomarkers in renal cell cancer If these tests prove reliable, they could reduce overtreatment by helping doctors distinguish benign masses from malignant ones without surgery. They would also allow for ongoing monitoring of patients on active surveillance with a simple blood draw rather than repeated scans. None of these tests are ready for routine clinical use yet, but they represent one of the more actively pursued frontiers in kidney cancer diagnostics.